Stay updated with breaking news from Evogene Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Evogene Ltd. (NASDAQ:EVGN – Get Rating)’s stock price crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.68 and traded as low as $0.61. Evogene shares last traded at $0.65, with a volume of 132,598 shares. Analyst Upgrades and Downgrades Separately, […]
Evogene Ltd. (NASDAQ:EVGN – Get Rating) saw a significant growth in short interest in May. As of May 15th, there was short interest totalling 288,700 shares, a growth of 13.4% from the April 30th total of 254,500 shares. Based on an average daily volume of 73,300 shares, the short-interest ratio is currently 3.9 days. Currently, […]
Lavie Bio Receives Canadian Regulatory Approval for ThrivusTM, Expanding Global Reach The approval by the Canadian Food Inspection Agency... | May 24, 2023
The approval by the Canadian Food Inspection Agency triples Thrivus'™ sales territory REHOVOT, Israel, May 24, 2023 /PRNewswire/ -- Lavie Bio Ltd., a subsidiary of Evogene Ltd. , and a... | May 24, 2023
Lake Street analyst Ben Klieve reiterated a Buy rating on Evogene (EVGN – Research Report) today and set a price target of $2.00. The comp...